"Metabolic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Descriptor ID |
D008659
|
| MeSH Number(s) |
C18.452
|
| Concept/Terms |
Metabolic Diseases- Metabolic Diseases
- Thesaurismosis
- Thesaurismoses
- Diseases, Metabolic
- Disease, Metabolic
- Metabolic Disease
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Diseases".
This graph shows the total number of publications written about "Metabolic Diseases" by people in this website by year, and whether "Metabolic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 4 | 1 | 5 |
| 2019 | 2 | 2 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
| 2023 | 4 | 0 | 4 |
| 2024 | 3 | 0 | 3 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metabolic Diseases" by people in Profiles.
-
Reactive Oxygen Species (ROS) in Metabolic Disease-Don't Shoot the Metabolic Messenger. Int J Mol Sci. 2025 Mar 14; 26(6).
-
Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025 Mar 06; 11(1):14.
-
Consensus on the key characteristics of metabolism disruptors. Nat Rev Endocrinol. 2025 Apr; 21(4):245-261.
-
Variance Between Clinical Guidance and Real-World Management of Metabolic Dysfunction-associated Steatotic Liver Disease in the United States. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):374-376.e3.
-
The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis. J Med Econ. 2024 Jan-Dec; 27(1):919-930.
-
Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II. Front Endocrinol (Lausanne). 2024; 15:1441828.
-
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. J Hepatol. 2024 03; 80(3):419-430.
-
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology. 2024 05 01; 79(5):1212-1219.
-
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. J Hepatol. 2023 12; 79(6):1524-1541.
-
Menstrual Cycle Irregularity in Adolescence Is Associated With Cardiometabolic Health in Early Adulthood. J Am Heart Assoc. 2023 09 19; 12(18):e029372.